Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-585251
Filing Date
2016-05-10
Accepted
2016-05-10 13:04:04
Documents
51
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d173739d10q.htm 10-Q 256044
2 EX-31.1 d173739dex311.htm EX-31.1 5989
3 EX-31.2 d173739dex312.htm EX-31.2 5960
4 EX-32.1 d173739dex321.htm EX-32.1 4124
5 EX-32.2 d173739dex322.htm EX-32.2 4100
  Complete submission text file 0001193125-16-585251.txt   2002023

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ccxi-20160331.xml EX-101.INS 355904
7 XBRL TAXONOMY EXTENSION SCHEMA ccxi-20160331.xsd EX-101.SCH 27970
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ccxi-20160331_cal.xml EX-101.CAL 41912
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ccxi-20160331_def.xml EX-101.DEF 60089
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ccxi-20160331_lab.xml EX-101.LAB 216851
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ccxi-20160331_pre.xml EX-101.PRE 149061
Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

EIN.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35420 | Film No.: 161634775
SIC: 2834 Pharmaceutical Preparations